B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, Yidan Chen, Bernd Jahrsdörfer, Carolin Ludwig, Hubert Schrezenmeier, Andreia C. Lino, Thomas Dörner
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2022-04-01
Cyfres:Frontiers in Immunology
Pynciau:
RTX (rituximab)
B-cells
vaccination
SARS – CoV – 2
prediction
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg